athenahealth, Inc. (NASDAQ:ATHN)‘s stock had its “buy” rating reaffirmed by equities researchers at Citigroup Inc. in a research report issued to clients and investors on Monday. They currently have a $186.00 price target on the health services provider’s stock, up from their previous price target of $169.00. Citigroup Inc.’s price objective would indicate a potential upside of 20.13% from the stock’s current price.

ATHN has been the subject of several other reports. UBS AG reissued a “buy” rating and set a $152.00 price objective (up from $123.00) on shares of athenahealth in a research note on Wednesday, May 31st. Piper Jaffray Companies reissued a “buy” rating and set a $152.00 price objective on shares of athenahealth in a research note on Friday, July 14th. Oppenheimer Holdings, Inc. raised their price objective on athenahealth from $154.00 to $184.00 and gave the stock an “outperform” rating in a research note on Friday. Wells Fargo & Company reissued an “outperform” rating and set a $190.00 price objective (up from $130.00) on shares of athenahealth in a research note on Saturday. Finally, BidaskClub lowered athenahealth from a “buy” rating to a “hold” rating in a research note on Tuesday, July 4th. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and thirteen have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $148.05.

athenahealth (ATHN) traded down 0.71% during trading on Monday, hitting $154.83. The stock had a trading volume of 615,345 shares. The stock has a market cap of $6.18 billion, a PE ratio of 196.48 and a beta of 1.79. The firm’s 50-day moving average price is $141.51 and its 200-day moving average price is $122.62. athenahealth has a 1-year low of $90.11 and a 1-year high of $156.86.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.12. The business had revenue of $301.10 million during the quarter, compared to analyst estimates of $298.68 million. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The company’s revenue was up 15.0% compared to the same quarter last year. During the same period last year, the company posted $0.34 EPS. On average, equities research analysts predict that athenahealth will post $1.89 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/07/24/athenahealth-inc-nasdaqathn-given-buy-rating-at-citigroup-inc.html.

In related news, SVP Bradford Kyle Armbrester sold 2,431 shares of athenahealth stock in a transaction dated Thursday, May 18th. The stock was sold at an average price of $130.00, for a total transaction of $316,030.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Brandon H. Hull sold 1,600 shares of athenahealth stock in a transaction dated Thursday, May 18th. The stock was sold at an average price of $130.00, for a total value of $208,000.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 26,105 shares of company stock worth $3,394,859. 3.20% of the stock is currently owned by company insiders.

A number of large investors have recently added to or reduced their stakes in the company. Kornitzer Capital Management Inc. KS increased its stake in athenahealth by 6.0% in the second quarter. Kornitzer Capital Management Inc. KS now owns 220,965 shares of the health services provider’s stock worth $30,495,000 after buying an additional 12,430 shares during the last quarter. Norges Bank bought a new stake in athenahealth during the fourth quarter worth $20,750,000. Morgan Stanley increased its stake in athenahealth by 3.5% in the fourth quarter. Morgan Stanley now owns 3,927,997 shares of the health services provider’s stock worth $632,290,000 after buying an additional 131,022 shares during the last quarter. Reynolds Capital Management bought a new stake in athenahealth during the fourth quarter worth $338,000. Finally, CIBC World Markets bought a new stake in athenahealth during the fourth quarter worth $1,620,000.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.